Methylphenidate hydrochloride and Vimpat drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Methylphenidate hydrochloride and Vimpat together.

The phase IV clinical study analyzes what interactions people who take Methylphenidate hydrochloride and Vimpat have. It is created by eHealthMe based on reports of 5 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 07, 2022

5 people who take Methylphenidate hydrochloride and Vimpat together, and have interactions are studied.

What is Methylphenidate hydrochloride?

Methylphenidate hydrochloride has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 5,261 Methylphenidate hydrochloride users for its effectiveness, alternative drugs and more.

What is Vimpat?

Vimpat has active ingredients of lacosamide. It is often used in epilepsy. eHealthMe is studying from 17,795 Vimpat users for its effectiveness, alternative drugs and more.

Number of Methylphenidate hydrochloride and Vimpat reports submitted per year:

Common Methylphenidate Hydrochloride and Vimpat drug interactions by gender *:

female:

Aggression
Nausea
Arthritis
Confusional state
Fall
Femoral neck fracture
General physical health deterioration
Nightmare
Sepsis
Thrombosis

male:

Therapeutic response unexpected

Common Methylphenidate Hydrochloride and Vimpat drug interactions by age *:

0-1:

n/a

2-9:

Therapeutic response unexpected

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Aggression
Arthritis
Confusional state
Fall
Femoral neck fracture
General physical health deterioration
Nightmare
Sepsis
Thrombosis

50-59:

Nausea

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Methylphenidate hydrochloride and Vimpat?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .